Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Astellas Pharma US Inc. recalls Astagraf XL (tacrolimus extended-release capsules) 0.5 mg

Class Iofficial

FDA Class I

FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.

Hazard
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
Products
  • Astagraf XL (tacrolimus extended-release capsules) 0.5 mg
Where it was sold

Nationwide in the USA

Nationwide

Units affected
3,500 30-count bottles
About this recall
Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.